The prototypic class Ia ribonucleotide reductase from Escherichia coli: still surprising after all these years

Author:

Brignole Edward J.12,Ando Nozomi12,Zimanyi Christina M.2,Drennan Catherine L.123

Affiliation:

1. Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, U.S.A.

2. Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, U.S.A.

3. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, U.S.A.

Abstract

RNRs (ribonucleotide reductases) are key players in nucleic acid metabolism, converting ribonucleotides into deoxyribonucleotides. As such, they maintain the intracellular balance of deoxyribonucleotides to ensure the fidelity of DNA replication and repair. The best-studied RNR is the class Ia enzyme from Escherichia coli, which employs two subunits to catalyse its radical-based reaction: β2 houses the diferric-tyrosyl radical cofactor, and α2 contains the active site. Recent applications of biophysical methods to the study of this RNR have revealed the importance of oligomeric state to overall enzyme activity and suggest that unprecedented subunit configurations are in play. Although it has been five decades since the isolation of nucleotide reductase activity in extracts of E. coli, this prototypical RNR continues to surprise us after all these years.

Publisher

Portland Press Ltd.

Subject

Biochemistry

Reference53 articles.

1. Increase in dNTP pool size during the DNA damage response plays a key role in spontaneous and induced-mutagenesis in Escherichia coli;Gon;Proc. Natl. Acad. Sci. U.S.A.,2011

2. Mechanisms of mutagenesis in vivo due to imbalanced dNTP pools;Kumar;Nucleic Acids Res.,2011

3. Stimulation of mutagenesis by proportional deoxyribonucleoside triphosphate accumulation in Escherichia coli;Wheeler;DNA Repair,2005

4. Discovery and development of clofarabine: a nucleoside analogue for treating cancer;Bonate;Nat. Rev. Drug Discovery,2006

5. Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′-deoxycytidine);Hertel;Cancer Res.,1990

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3